Literature DB >> 21177635

Vibrio parahaemolyticus infection induces modulation of IL-8 secretion through dual pathway via VP1680 in Caco-2 cells.

Takaaki Shimohata1, Masayuki Nakano, Xin Lian, Tomomi Shigeyama, Hitomi Iba, Akiko Hamamoto, Masaki Yoshida, Nagakatsu Harada, Hironori Yamamoto, Masayuki Yamato, Kazuaki Mawatari, Toshiaki Tamaki, Yutaka Nakaya, Akira Takahashi.   

Abstract

BACKGROUND: Vibrio parahaemolyticus causes acute gastroenteritis and inflammations in humans. A variety of pathogenic bacteria can stimulate mitogen-activated protein kinases (MAPKs) in host cells. Phosphorylation of MAPKs leads to production of interleukin (IL)- 8 and subsequently causes inflammations. Thus, MAPK cascades were strong candidates for the main signaling pathway of V. parahaemolyticus-induced acute inflammation.
METHODS: To determine whether the signaling pathway on V. parahaemolyticus infection induces inflammation, we analyzed the secretion level of IL-8 and phosphorylation of MAPKs by use of intestinal epithelial Caco-2 cells.
RESULTS: V. parahaemolyticus infection of Caco-2 cells activated extracellular signal-regulated kinase (ERK) 1/2 and p38 MAPK signal pathways, leading to IL-8 secretion, whereas MAPK inhibitors, UO126 or SB203580, suppressed IL-8 secretion. A strain carrying a deletion of VP1680, a type three secretion system 1 (T3SS1) effector protein, failed to activate phosphorylation of ERK1/2 and p38 MAPK and secretion of IL-8. ERK1/2 pathway inhibitor, UO126, failed IL-8 promoter activity, whereas p38 MAPK inhibitor, SB203580, decreased the stabilization of IL-8 messenger RNA following V. parahaemolyticus infection.
CONCLUSIONS: We showed that V. parahaemolyticus infection of Caco-2 cells results in the secretion of IL-8, and that VP1680 plays a pivotal role in manipulating host cell signaling and is responsible for triggering IL-8 secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177635      PMCID: PMC3071237          DOI: 10.1093/infdis/jiq070

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae.

Authors:  Kozo Makino; Kenshiro Oshima; Ken Kurokawa; Katsushi Yokoyama; Takayuki Uda; Kenichi Tagomori; Yoshio Iijima; Masatomo Najima; Masayuki Nakano; Atsushi Yamashita; Yoshino Kubota; Shigenobu Kimura; Teruo Yasunaga; Takeshi Honda; Hideo Shinagawa; Masahira Hattori; Tetsuya Iida
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

2.  Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades.

Authors:  Guntram A Grassl; Michael Kracht; Agnès Wiedemann; Elke Hoffmann; Martin Aepfelbacher; Christoph von Eichel-Streiber; Erwin Bohn; Ingo B Autenrieth
Journal:  Cell Microbiol       Date:  2003-12       Impact factor: 3.715

3.  Vibrio parahaemolyticus infections in the United States, 1973-1998.

Authors:  N A Daniels; L MacKinnon; R Bishop; S Altekruse; B Ray; R M Hammond; S Thompson; S Wilson; N H Bean; P M Griffin; L Slutsker
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

4.  Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells.

Authors:  M de Grado; C M Rosenberger; A Gauthier; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 5.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

6.  Adaptive and inflammatory immune responses in patients infected with strains of Vibrio parahaemolyticus.

Authors:  Firdausi Qadri; Muhammad Shamsul Alam; Mitsuaki Nishibuchi; Taufiqur Rahman; Nur Haque Alam; Jobayer Chisti; Seiichi Kondo; Junichi Sugiyama; Nurul Amin Bhuiyan; Minnie M Mathan; David A Sack; G Balakrish Nair
Journal:  J Infect Dis       Date:  2003-03-19       Impact factor: 5.226

7.  Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells.

Authors:  Stephanie Dahan; Valere Busuttil; Veronique Imbert; Jean-Francois Peyron; Patrick Rampal; Dorota Czerucka
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

8.  Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection.

Authors:  D Czerucka; S Dahan; B Mograbi; B Rossi; P Rampal
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus.

Authors:  Kwon-Sam Park; Takahiro Ono; Mitsuhiro Rokuda; Myoung-Ho Jang; Tetsuya Iida; Takeshi Honda
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

10.  Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis.

Authors:  Dara L Burdette; Melanie L Yarbrough; Anthony Orvedahl; Christopher J Gilpin; Kim Orth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

View more
  20 in total

1.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.

Authors:  Mohd Akhlakur Rahman; Zhihui Cheng; Junji Matsuo; Yasuko Rikihisa
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

3.  Vibrio effector protein, VopQ, forms a lysosomal gated channel that disrupts host ion homeostasis and autophagic flux.

Authors:  Anju Sreelatha; Terry L Bennett; Hui Zheng; Qiu-Xing Jiang; Kim Orth; Vincent J Starai
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

Review 4.  Vibrio variations on a type three theme.

Authors:  Kelly A Miller; Katharine F Tomberlin; Michelle Dziejman
Journal:  Curr Opin Microbiol       Date:  2019-01-31       Impact factor: 7.934

5.  The Vibrio parahaemolyticus ToxRS regulator is required for stress tolerance and colonization in a novel orogastric streptomycin-induced adult murine model.

Authors:  W Brian Whitaker; Michelle A Parent; Aoife Boyd; Gary P Richards; E Fidelma Boyd
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

6.  DNA-Binding Protein HU Coordinates Pathogenicity in Vibrio parahaemolyticus.

Authors:  Ngoc Quang Phan; Takashi Uebanso; Takaaki Shimohata; Mutsumi Nakahashi; Kazuaki Mawatari; Akira Takahashi
Journal:  J Bacteriol       Date:  2015-07-06       Impact factor: 3.490

Review 7.  Vibrio parahaemolyticus cell biology and pathogenicity determinants.

Authors:  Christopher A Broberg; Thomas J Calder; Kim Orth
Journal:  Microbes Infect       Date:  2011-07-07       Impact factor: 2.700

8.  The cytotoxic type 3 secretion system 1 of Vibrio rewires host gene expression to subvert cell death and activate cell survival pathways.

Authors:  Nicole J De Nisco; Mohammed Kanchwala; Peng Li; Jessie Fernandez; Chao Xing; Kim Orth
Journal:  Sci Signal       Date:  2017-05-16       Impact factor: 8.192

9.  Genetic diversity of clinical and environmental Vibrio parahaemolyticus strains from the Pacific Northwest.

Authors:  Rohinee Paranjpye; Owen S Hamel; Asta Stojanovski; Martin Liermann
Journal:  Appl Environ Microbiol       Date:  2012-10-05       Impact factor: 4.792

10.  A cytotoxic type III secretion effector of Vibrio parahaemolyticus targets vacuolar H+-ATPase subunit c and ruptures host cell lysosomes.

Authors:  Shigeaki Matsuda; Natsumi Okada; Toshio Kodama; Takeshi Honda; Tetsuya Iida
Journal:  PLoS Pathog       Date:  2012-07-19       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.